Table 2.
Characteristics of glucose metabolism and CMR parameter
| All | With LVRR (n = 57) |
Without LVRR (n = 144) |
p Value | |
|---|---|---|---|---|
| Glucose metabolism, n(%) | 0.401 | |||
| DM | 79 (39%) | 20 (35%) | 59 (41%) | |
| IGT | 78 (39%) | 21 (37%) | 57 (40%) | |
| NGT | 44 (22%) | 16 (28%) | 28 (19%) | |
| glucose on admission, mg/dl | 156 (133–196) | 152 (128–186) | 158 (136–205) | 0.263 |
| HbA1c, % | 5.9 (5.5–6.4) | 5.8 (5.5–6.2) | 5.9 (5.5–6.5) | 0.518 |
| CGM parameter | ||||
| MAGE, mg/dl | 48 (32-63.9) | 33.5 (24.1–54.9) | 53.1 (38.6–68.3) | 0.002 |
| Max glucose level, mg/dl | 170 (148–210) | 151 (139–190) | 179 (154–213) | 0.044 |
| Minimum glucose level, mg/dl | 96 (83–104) | 98 (82–104) | 94 (85–105) | 0.735 |
| Incidence of hypoglycemia, n (%) | 11 (5%) | 3 (5%) | 8 (6%) | 1.000 |
| Average glucose level, mg/dl | 121 (112–136) | 119 (110–127) | 122 (112–138) | 0.926 |
| early CMR | ||||
| IS, % of LV mass | 15 (9.75-22) | 16 (11–24) | 15 (9–22) | 0.250 |
| AAR, % of LV mass | 27 (19–40) | 29 (19–40) | 26 (18–39) | 0.214 |
| MSI | 0.44 (0.30–0.56) | 0.41 (0.30–0.56) | 0.44 (0.3–0.56) | 0.717 |
| Presence of MVO, n (%) | 57 (42%) | 22 (39%) | 63 (44%) | 0.505 |
| Transmural infarction, n (%) | 104 (52%) | 25 (44%) | 79 (55%) | 0.160 |
DM, diabetes mellitus; IGT, impaired glucose tolerance, NGT, normal glucose tolerance; CGM, continuous glucose monitoring; MAGE, mean amplitude of glycemic excursion, CMR, cardiac magnetic resonance imaging; IS, infarct size; AAR, area at risk; MSI, myocardial salvage index; MVO, microvascular obstruction; LV, left ventricular; EF, ejection fraction; EDVI, end-diastolic volume index; ESVI, end-systolic volume index